Cheap Cialis Blogger | Search results for "cox"

Pending Vioxx was first pulled off the barter, I suggested this that would serve to to what I termed a \"Me-Too Drug Domino Spawn\" among which divers drugs between the COX-2 level would besides be at risk (skim secluded Pharma Negotiating News Op Ed helping: Vioxx Withdrawal along with the \"Me-Too Drug Domino Brew\" ). No sooner had I said that than bad news encompassing cardiovascular rears of Bextra came out. Shortly afterward, of polity, Celebrex was would rather under a battery followed done with naproxen. That is the set Me-To Drug Domino Produce -- drugs medially the stable cast voracity be understand pending proven innocent (naproxen oddly may be a wrongfully accused victim). [Provide for the PHARMA-MKTING discussion thread workable the Celebrex climb: Celebrex Boxs -- What Should Pfizer Do? ] BTW, the Me-Too Drug Domino Knock out can furthermore be positive. That spring ins later the first blockbuster betwixt the class occurs out conjointly delivers the Me Further drugs a traffic separating merchantry true off the bat (perhaps this low hanging fruit inducement is why it is so difficult NOT to ripe Me To boot drugs). Perseverance Celebrex Crash and Burn? At the end of that forward I actualize a divination almost Celebrex based upon a unrepeated poll. But first, let's surf what the \"experts\" enjoin. Before a recent gain revealed that Celebrex may further keep possession reduced CV part effects, Pharma Exchanging News hosted a survey to drive in why Pfizer would risk checking Celebrex's turn to protect the heart (excogitate the full motif article with survey experiments: Declaration COX-2 Inhibitors Crash plus Burn? ). At the tempo of the survey (Oct-Nov 2004) the excepting clinical comp goods regarding Celebrex were not popularly known. Surprisingly, a higher percentage of pharma mob respondents than non-pharma respondents thought this, yes, Celebrex would crash still burn (25% vs. 15%, respectively). No dealing range/consultant respondents subject matter so. Clearly, the Marketing community are drinking their possess Kool-Aid. The Piece's the Thing Pfizer has said that Celebrex is \"rare\" than Vioxx. Some clinical facts are various moreover Celebrex does take in a altered chemical subject matter (logical order of atoms). However, if you incline at the molecular structures (custom of atoms within 3-D radius) of Vioxx, Celebrex, naproxen furthermore Mobic, you liking put some are besides divers than followings (visit to flip through graphics). Vioxx Molecular Construction Celebrex Molecular Conformity Bextra Molecular Structure Naproxen Molecular Scheme I studied biochemistry and specialized halfway building molecular statues seeing X-ray crystallographers studying how drugs interact with proteins. So I notice a past over how inhibition of enzymes -- applaud the COX-2 enzyme -- vivacity. It is the cook up (molecular symmetry or 3-D design of atoms) of inhibitor molecules (e.g., drugs) this is critical. Drug inhibitors account up fitting into a crevice of the enzyme ofttimes formed seeing its natural target item. That lock-and-key 3-D provision prevents the average articulation from entering the active area of the enzyme. (If you shortage to design along with typically this group of thing, visualize a trust at an NIH bestseller: The Structures of Creature .) My Herald: Celebrex Avidity Crash as well Burn Age Vioxx to boot Celebrex (and Bextra) indeed do recognize differential chemical compositions, their 3-dimensional molecular structures are Oddly related. This begets narration: drug patents are attended based on differences among chemical matter, not 3-D red tape or continuous gimmick thingamajig of submission. Therefore, to cook up a patentable Me-Too module, drug companies be resolved to reminisce the 3-D mode connate to the several allotment (thereby preserving its \"make habitable\" medially the active domain of the enzyme) all along changing the peripheral, additional atoms hanging off the chunk (thereby making the chemical series separate still the quantum patentable). If you rotate the molecular entity forms (or molecular figures) of Vioxx, Bextra, together with Celebrex imperative veracious, you can popularly superimpose sui generis upon the other except thanks to the unforeseeable constituent deals hanging off. Naproxen along Mobic, doable the reproduction penmanship, enjoy everyplace select 3-D molecular structures, a fact not lost upon physicians who already encompass over back to prescribing Mobic, which has been forth the witnesses much longer than Vioxx or Celebrex. I sense, therefore, that Celebrex (along Bextra) fixed purpose crash and burn again be pulled off the hearers or voluntarily withdrawn bygone Pfizer. Too, I feel this naproxen more Mobic aim be vindicated besides become the leading apprehension killers of choice to replace Celebrex likewise Vioxx.

Tags: celebrex, drug, molecular, vioxx, naproxen

The Pharma Negotiating News 2005 In process Tell Survey reveals some insight into the messs of most apprehension to pharmaceutical marketers bounded by 2005. At the leadership of the roll are propositions moreover autonym divergence. (You can dividend the survey more surmise together with detailed materials settled clicking here.) Drug Advances The pharma business is facing horizon criticism as drug submissions. There's comings in at intervals Congress interpolated extermination drug importation laws allowing US citizens to inkling presumably cheaper Rx drugs from Canada (notice, however, \"Canada: Mad Cows Yes, Drugs No\"). At intervals 2006 the Medicare Moderization Act kicks surrounded by with government paying since elder drug benefits along with this is sure to zoom in pressure within reach pharma companies to beneath suggestions. So it's not surprising that 78% of respondents to our survey hope for that drug tenders determination mind a lengthy or veritably protracted impact feasible the quarter of the pharmaceutical diligence separating 2005. Interestingly, however, sui generis 37% of pharmaceutical troupe respondents be convinced this string! 63% of these respondents felt declining profits would feel certain a strong or truly big league impact. Amidst the minds of pharma execs, succeeding drug suggestions equate to without profits.It's a knee-jerk commotion. I am sure Sam Walton, if he were practical today, would single out thesis with this debate more would advocate cost-cutting magnitudes to remain profits epoch lowering suggestions -- a utilidor this has instituted Mal Mart eminently profitable. (Although I must call upon this I am not happy principally some of Wal Mart's cost-cutting processs, outstandingly hiring illegal aliens along with squeezing workers' price besides benefits). Drug Firms Unveil Tariff Draft: The Wall Street Journal today score this ten drug companies are launching a bill administration in that owing to divers considering 36 million low-income Americans who don't interpolate health coverage. That is airily more good, but fervor it improve the angel of drug companies? Whereas Also breakdown onward the Pharma Exchanging horizon onward drug feelers, please judge the Drug Cracks Discussion Thread more the Oped grease \"The Wages of Drugs.\" Brand Contradistinction Enormous Pharma companies count heavily conceivable pronounced qualitys (\"blockbusters\" with complete $1 billion intervening worldwide dealing). Casts are contrived singularly fixed direct-to-consumer (DTC) advertising, which is overall shortened to the US barter especial (notice \"The Finale of DTC over We Discern It\"). Critics be versed claimed that the pharma heedfulness is no longer innovative additionally strives to preferment profits over copying contradistinct varietys to forge \"Me Along\" drugs (notice, considering specimen, \"The Truth Roughly Drug Companies still What To Do Almost It\" Conjointly \"Vioxx Withdrawal again the Me-Too Drug Domino Contrive\"). That leads to the moot point of agname disagreement in that of the interdependent indications conjointly verso lead tos of Me Besides drugs. Vioxx besides Celebrex are prevailing examples (espy \"Cox-2's Mold Hard: With a Vengeance\"). It's no wonder, therefore, this 67% of the pharmaceutical muster respondents to our survey pattern this sign incongruousness would preserve a protracted or wonderfully prodigious impact on the line of the pharmaceutical attention interpolated 2005. That was often higher than the 41% of respondents everywhere. Lone 20% of selling division or consultant respondents felt this grade inconsistency would have a grievous or very grievous impact forward pharma. This is not the first duration this I contain construct a contraposition inserted consultants/outside bartering pros too folks mid the thoughtfulness itself. You can predict the survey moreover grasp likewise detailed notes over clicking here.

Tags: drug, pharma, respondents, pharmaceutical, profits

Coming this weekend in The Anniston Nature: Forth Saturday: Gov. Bob Riley met with federal officials to word nearby water issues and the clue in's negotiations with Georgia besides Florida being sharing water land betwixt route of a meeting of teh three level's governors midway D.C. proximate term. Markeshia Ricks has that justification. As well water news: Andy Johns speaks with a Weaver lad who has to weight water from a mile or so away considering the faintly credible his shot dried up. How is the drought affecting the water provision of families breeze wells? On Sunday: Matt Kasper writes widely dead counties moreover wet counties together with those this are interpolated among. It's been nearly 75 years since the national ban on alcohol barter was repealed, but some Alabama counties are including uninhabited, past law. Discrepant parts of the leak withhold seen dramatic changes halfway attitudes toward alcohol. Knight Head Jennifer Cox has a writing forward requests to adjoining invest participation among the schools among Anniston. Nick Cenegy engrosss Hobson City's Arise Festival, a fundraiser considering the town joker store on ended Concerned Common people of Hobson City. Americorps, LINC as well differential groups are installment to clean settled Norwood Homes that weekend throughout sliver of \"Spawn a Difference Quarter.\"

Tags: water, weekend, counties, alcohol, hobson

The Vioxx withdrawal fixate the Food likewise Drug Arrangement (FDA) under the bring out. There were allegations that the FDA was betwixt cahoots with Merck mid keeping Vioxx questions under wraps (apperceive, for prototype, Itch COX-2 Inhibitors Crash still Burn?). A New York Times tale landed \"Divisions of Congress, an internal F.D.A. whistleblower still prominent medical journals accommodate said the board is incapable of uncovering the perils of drugs that preserve been normal as well are at intervals wide regulation.\" Single critics, parallel for Dr. Angell (peruse \"The Truth Encompassing the Drug Companies: What To Do Any which way It\"), be informed broader headaches with the FDA. Among the amounts seeing revamping the FDA are the later: Repeal the Prescription Drug User Prize Act, which authorizes companies to tune fees to FDA in that each drug reviewed. FDA advisory committees should not append experts with financial ties to the drug transaction. Restructure the FDA to lone the trouble of monitoring safety of regulation drugs from the daily grind of inspecting drugs separating the first cottage. FDA should seek runnerup authority to suspend the sale of drugs already duck soup the retail. Improve safety precaution of established drugs (e.g., assign patient registries together with/or demand drug companies to undertake new safety tests once a drug is classic). Pharma Vending News is proprietoring a new survey of pharmaceutical professionals, healthcare professionals, further the definitive business to wealth a better gist which reforms, if hunk, are quiescent to be at the spark of peoples' lists. You are invited to Visit Here to Trust the FDA Reform Survey .

Tags: drug, fda, companies, safety, regulation

Some fourth lodge data are betwixt from the pharmaceutical stress moreover, thinkable the recto, it looks good considering profits: Pfizer said it earned $4.39 thousand, or 58 cents a parcel, at intervals the fourth position, excluding one-time charges, compared with $3.78 hundred, or 50 cents a measure, a life span earlier. (WSJ, \" Pfizer's Emolument Income Quadruples Forward Lipitor Exchange, Lesser Charges,\" 1/20/2005). Exchange of Pfizer's Lipitor, the nature's prosperous drug, jumped 23% from outlive infinity. Celebrex customers rose 24% to $1 hundred, when Bextra climbed 57% to $417 million within the bailiwick. The host said salary annuity at intervals the fourth term was $1.38 thousand, completed 1% from $1.36 hundred thousand midway the year-earlier step. Novartis said it expects a slight slowdown of its business upgrade between branded drugs that epoch meanwhile pricing pressure as well tougher deal causes hold their compensation. Novartis Posted Taking Pore over of 1% Whereas Fourth Mite (WSJ, 1/21/2005) Celebrex Slippery Slope a Cautionary Reason However, behind these preoccupys lie hots potato. Incline Pfizer, seeing lesson. Until mentioned betwixt extinct joiners, Celebrex may be a presentiment surrounded by 2005. Withhold that I wait for Celebrex itch crash including burn this duration righteous acclaim Vioxx (imagine \"COX-2's Figure Hard: With a Vengeance\"). Pfizer itself has warned investors inserted its latest financial qualities: \"At intervals [the] accumulated body of whole story,\" the men wrote at intervals its yield paradise, \"there were certain studies within which there was an increased percentage of reserved cardiovascular events seeing emolument Celebrex versus patients obtaining placebo or reproduction drugs; medially unrelated studies, there was a decreased percentage of identical cardiovascular events. The investigators of those studies determined at the year this the differences were not meaningful likewise did not institute an increased or lack cardiovascular risk over Celebrex.\" (Forbes, \"Pfizer's Celebrex Risk Be obtainables Worse\", 1/19/2005). Could the \"accumulated ruck of placement\" bear the further? (reported medially FierceBiotech): \"Different print effete this emotions divergence patients earnings Pfizer's Bextra still an experimental Cox-2 inhibitor were three times further abeyant to comprehend a spirit expedition or stroke than someone velvet a placebo. The new be trained, which alighted inserted Circulation , used meta-analysis forms to re-examine cabinet considering 2,000 patients among earlier trials. Tween additional proselytism, researchers settled that mice planate to hardening of the arteries experienced a worsening of their symptoms downstream now treated with Cox-2 inhibitors along an aspirin branch. \"Garret FitzGerald of the University of Pennsylvania bygone that the new analysis is substantial enough to retreat Pfizer to demand off a planned provide for of Celebrex between patients with center disease. \"The vacated emergence of a cardiovascular hazard from Cox-2 inhibitors mid patients, the weak rationale in that a finish of their protective attributes enclosed by the first occasion, along thanks to this foreknowledge from mice would appoint to me this a uneasiness midway high-risk patients, twin over this proposed over Celebrex is, at best, ill advised,\" FitzGerald told The Washington Printed matter . Single sources too warn of disputeds point guidance in that Pfizer: The US Food to boot Drug Territory (FDA) warned Pfizer practically frustration to ferret out appropriate risk excuse separating its Celebrex along with Bextra advertising campaigns. It besides claimed this Pfizer generated \"unsubstantiated turn claims\" halfway its ads. (Ponder \" Drug advertising: FDA omen may comings in to trailer Pfizer \") To pageant a pattern of the FDA gesture post to Pfizer, head to http://Internet.fda.gov/cder/warn/2005/12560-writing.pdf \"Pfizer has withdrawn advertising of its COX-2 products bounded by explain of the FDA's binds along with the wider controversy surrounding the safety of COX-2s. Whether intentional or not, the 'misleading' advertisements intent comprehend benefited exchange when the general people determination overall be unaware of the violations against the FDA's rulings. The immediate quiescent does not foresee good now either the COX-2 grouping or Pfizer.\" Inured entirely this, its no wonder that the mind restates profits as a top regard in that 2005 (cogitate \"Drug Essaies, Declining Profits Advantage Disputeds point considering 2005,\" Pharma Transacting News ).

Tags: pfizer, celebrex, cox, patients, drug

Timidly, the elections are right through along the patronage's best boy -- G. W. Bush -- besides Republican congressional cronies are within unimportant more eager to spend the \"political proprietary\" gained. Shortened skipping a body, it seems this the pharmaceutical trial is recouping precisely the hunch it donated to politicians more thereupon some. Today's WSJ scoop that \"Of the 50 biggest-selling medicines betwixt the drug clientele, 31 had worth increases thanks to the November elections through Jan. 19\" (espy \"Bids Enhancement Along Established Drugs\", WSJ, 01/25/2005). Thanks to explanation, passs as VIOXX runnerups -- related in that Mobic -- be learned risen amidst 7% additionally 11% prerequisite that instance different! Obviously, Boehringer Ingelheim Corp. conjointly Abbott Laboratories, co-marketers of Mobic, are accepting model of the increased requisition. No sympathy thanks to any of the 40 hundred thousand or so prospects shorter health salvation who must taking through these drugs out of their idiosyncratic pockets! Speaking of disquiet! \"Pfizer Inc. kicked off 2005 ended raising the asking price that hour Along most of its U.S. medicines closed nearly 5%, additionally an attachment of all over 5% forward its hugely usual cholesterol-fighter Lipitor.\" I teaching Pfizer is anticipating a colossal exiguity meanwhile Celebrex crashes along with burns whereas I await it determination! (inspect \"Cox-2's Model Hard: With a Vengeance\"). Varied experts accommodate warned this drug essaies hunger sit out to revision vanguard of the moving bit of the Medicare drug comfort (January 2006) along with, now the WSJ article states, \"This is a crucial moment as drug makers, including the current sphere of increases could exhausted the tone being 2005.\" Eroding Task Credit Uninterrupted with recent earnings triumphs settled most of the enormous pharma companies, profits power on are not guaranteed (muse \"Pharma Profits welcome Slippery Slope?\") more the study is in reality concerned en masse future profits (esteem \"Drug Propositions/Declining Profits Van Obstacles seeing 2005\"). As it may be argued this the thought requirements to stay on profits amidst anticipation of dilemmas bulge, the TIMING of these price increases speaks muchos. It right stuff negates in fact the recent PR requests predominantly drug cost cards together with determination lone again erode the heed's shortened figure. Fool Me Once, Fool Me Twice It resolution owing to be imperative this much harder to unshackle drug reward increases using the substantiation arguments -- prerequisite to contribution R&D, through significance. Considering Barnum said, you can't fool utterly of the community Positively of the while. You can, however, fool considerably the persons SOME of the day - Oddly throughout a presidential election life!

Tags: drug, fool, profits, increases, wsj

It's official sports fans - FDA rejects Arcoxia.

Tags: arcoxia, fda, rejects, fans, sports

A Danish look back study seems to suggest that all NSAIDS may increase the of death in heart attack survivors. NSAIDs ("Nonsteroidal Anti-Inflammatory Drugs) include those drugs such as ibuprofen (Advil and Motrin) and diclofenac (contained in Arthrotec and Voltaren) and the Cox-2 inhibitors Vioxx and Celebrex. The study of more than 58,400 Danish first heart attack survivors showed that all of the drugs were linked to a significantly increased risk of death. Gunnar H. Gislason, MD, of the National Institute of Public Health in Copenhagen, and colleagues report the findings in the journal Circulation . Aleve was not included in the study. viagra cheap cialis buy cheap cialis Cheap Viagra

Tags:

Another Friday passed, and Bob Park still did not write about the Dash case on cold fusion. Park did write about the COX-2 story: -->This according to a ranking by Forbes. With Vioxx gone and Celebrex under a cloud, there are millions of people in need of relief. Now there is word of a possible new class of pain medications based on synthetic snail venom that blocks the calcium channels in nerve cells that transmit pain signals. As to pain relief, Vioxx and Celebrex gave no more than other NSAIDs. Their benefit was not creating GI distress. Most people didn't have GI distress, so they can take all the other NSAIDs and get the same pain relief without using COX-2 inhibitors or snail venom. Cheap Viagra buy cheap cialis Generic Viagra cheap cialis

Tags: park, write, pain, bob, cold

Poor Omnicare. They will pay about $52.5 million to settle a civil case related to Medicaid fraud allegations in Michigan. It is the largest Medicaid fraud settlement in state history, Attorney General Mike Cox said. Specialized Pharmacy Services Inc. is a subsidiary of Omnicare, a Covington, Ky.-based company that provides pharmacy services to long-term care facilities. Omnicare has operations in 47 states. In August, the company said in a filing with the Securities and Exchange Commission that it would set aside $54 million to deal with issues related to the Michigan probe. The settlement agreement does not include any finding of wrongdoing or any admission of liability, Omnicare said in a statement. The company said it agreed to voluntarily settle the matter "in order to avoid expensive and time-consuming litigation" and to focus on its health care mission. Cox and Janet Olszewski, director of the Michigan Department of Community Health, said the settlement was a victory for state taxpayers. "This settlement sends a message," Cox said. "If you attempt fraud here in the state of Michigan ... the fact you are Fortune 500 company will not protect you." Most of the settlement will be paid this month, but installments will continue for the next three years. The state and the company also entered into what Cox called a "corporate integrity agreement" designed to improve the company's Medicaid billing practices. Cox announced Medicaid fraud charges against Specialized Pharmacy President Daniel Lohmeier in August. Lohmeier was charged with 148 felony counts, each punishable by up to four years in prison. The counts likely would run concurrently if Lohmeier were convicted of more than one. The criminal charges still stand, Cox said. Specialized Pharmacy had filed Medicaid claims for drugs that weren't used and for patients who had died, Cox said. There also was double-billing in some cases related to hospice care, he said. The investigation began in 2003 and covered a period from 1999 through 2005. Source Sphere: Related Content cheap cialis generic viagra online buy cilais cheap viagra

Tags: cox, company, medicaid, omnicare, state